Molecular and functional characterization of CD133 + stem/progenitor cells infused in patients with end-stage liver disease reveals their interplay with stromal liver cells-Reference-Cited by-同舟云学术

Molecular and functional characterization of CD133 + stem/progenitor cells infused in patients with end-stage liver disease reveals their interplay with stromal liver cells

Published:2017-12 Issue:12 Volume:19 Page:1447-1461
ISSN:1465-3249
Container-title:Cytotherapy
language:en
Short-container-title:Cytotherapy

Author:

Catani Lucia,Sollazzo Daria,Bianchi Elisa,Ciciarello Marilena,Antoniani Chiara,Foscoli Licia,Caraceni Paolo,Giannone Ferdinando Antonino,Baldassarre Maurizio,Giordano Rosaria,Montemurro Tiziana,Montelatici Elisa,D'Errico Antonia,Andreone Pietro,Giudice Valeria,Curti Antonio,Manfredini Rossella,Lemoli Roberto Massimo

Publisher

Elsevier BV

Subject

Cancer Research,Transplantation,Cell Biology,Genetics(clinical),Oncology,Immunology,Immunology and Allergy

Reference55 articles.

1. The global impact of hepatic fibrosis and end-stage liver disease;Lim;Clin Liver Dis,2008

2. Hepatic fibrosis: concept to treatment;Trautwein;J Hepatol,2015

3. Liver cirrhosis;Schuppan;Lancet,2008

4. Perisinusoidal stellate cells (fat-storing cells, interstitial cells, lipocytes), their related structure in and around the liver sinusoids, and vitamin A-storing cells in extrahepatic organs;Wake;Int Rev Cytol,1980

5. Pathobiology of liver fibrosis: a translational success story;Lee;Gut,2015

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stem cell therapy for hepatocellular carcinoma and end-stage liver disease;Journal of the Egyptian National Cancer Institute;2023-11-06

2. Endogenous Bone Marrow-Derived Stem Cell Mobilization and Homing for In Situ Tissue Regeneration;Stem Cells;2023-04-15

3. Granulocyte colony-stimulating factor reduces biliary fibrosis and ductular reaction in a mouse model of chronic cholestasis;Liver Research;2023-03

4. Adult Stem Cell Therapy as Regenerative Medicine for End-Stage Liver Disease;Advances in Experimental Medicine and Biology;2022

5. Multiple Cycles of Granulocyte Colony-Stimulating Factor Increase Survival Times of Patients With Decompensated Cirrhosis in a Randomized Trial;Clinical Gastroenterology and Hepatology;2021-02